甲状腺毒症周期性瘫痪与rs312691多态性关联的meta分析

doi:10.3969/j.issn.1004-583X.2020.02.005

临床荟萃

甲状腺毒症周期性瘫痪与rs312691多态性关联的meta分析

成都市第三人民医院内分泌代谢病科，四川成都 610031

出版日期:2020-02-20 发布日期:2020-03-24
通讯作者: 钟晓卫，Email: zhongxw5413@163.com

Association between rs312691 polymorphism and susceptibility to thyrotoxic periodic paralysis: a metaanalysis

Department of Endocrinology and Metabolism, the Third People's Hospital of Chengdu, Chengdu 610031, China

Online:2020-02-20 Published:2020-03-24
Contact: Corresponding author: Zhong Xiaowei, Email: zhongxw5413@163.com

摘要/Abstract

摘要： 目的探讨KCNJ2基因下游rs312691多态性是否与甲状腺毒症周期性瘫痪（thyrotoxic periodic paralysis, TPP）发病有关。方法计算机检索PubMed、Embase、万方和中国知网数据库，收集关于rs312691单苷酸多态性（single nucleotide polymorphism, SNP）与TPP的病例对照研究文献。利用meta分析的方法评价该位点多态性与TPP之间的关系。结果共纳入7篇文献，共计961例患者，其中TPP组610例，对照组351例。Meta分析结果显示rs312691多态性与TPP的发生有关（OR=3.072，95%CI 2.5903.643，P＜0.01），剔除对照组不符合哈-温平衡后的亚组分析依然显示rs312691能增加TPP的风险（OR=2.804，95%CI 2.3043.413，P＜0.001）。结论 rs312691单核苷酸多态性能增加发生TPP的风险。

关键词: 甲状腺毒症, 格雷夫斯病, 低钾性周期性麻痹, rs312691, KCNJ2

Abstract: Objective To determine whether rs312691 polymorphism downstream of KCNJ2 confers susceptibility to thyrotoxic periodic paralysis (TPP). Methods Pubmed, Embase, Wanfang Chinese Periodical Database and China National Knowledge Infrastructure were systematically searched for control study related rs312691 polymorphism to thyrotoxic periodic paralysis. A metaanalysis was conducted on the association between the rs312691 polymorphism and TPP. Results A total of 7 comparison studies including 610 patients and 351 controls were considered in the metaanalysis. The metaanalysis showed a positive association between TPP and allele C of the rs312691 polymorphism in all study subjects (OR=3.072，95%CI 2.5903.643，P＜0.001). Stratification by HardyWeinberg equilibrium of the control group also identified significant positive association between this polymorphism and the susceptibility of TPP (OR=2.804，95%CI 2.3043.413, P<0.001). Conclusion This metaanalysis shows that the rs312691 polymorphism confers susceptibility to thyrotoxic periodic paralysis.

Key words: thyrotoxicosis, Graves disease；hypokalemic periodic paralysis；rs312691； KCNJ2

严同，钟晓卫，傅徐泉，李华琦，刘宜东，黄晓飞. 甲状腺毒症周期性瘫痪与rs312691多态性关联的meta分析[J]. 临床荟萃, doi: 10.3969/j.issn.1004-583X.2020.02.005.

Yan Tong, Zhong Xiaowei, Fu Xuquan, Li Huaqi, Liu Yidong, Huang Xiaofei. Association between rs312691 polymorphism and susceptibility to thyrotoxic periodic paralysis: a metaanalysis[J]. Clinical Focus, doi: 10.3969/j.issn.1004-583X.2020.02.005.

导出引用管理器 EndNote|Ris|BibTeX

链接本文: https://huicui.hebmu.edu.cn/CN/10.3969/j.issn.1004-583X.2020.02.005

https://huicui.hebmu.edu.cn/CN/Y2020/V35/I2/123

[1]	李蕾, 赵永超, 郑加香. 儿童Graves病的诊治新进展[J]. 临床荟萃, 2023, 38(5): 477-480.
[2]	冯尚勇;张真稳;闫彩凤;朱妍. 568例格雷夫斯病行131碘治疗1年随访研究[J]. 临床荟萃, 2014, 29(5): 549-551.
[3]	冯荣芳;郝志华;王建华;刘惠卿;王天俊. 继发于干燥综合征的低钾性麻痹1例[J]. 临床荟萃, 2014, 29(11): 1310-1312.
[4]	李忱;刘晋河. 胫前黏液性水肿的研究进展[J]. 临床荟萃, 2014, 29(10): 1198-1200.
[5]	何珂;胡蕴;郭慕红;毛晓明. 促甲状腺激素受体抗体对人肝癌细胞HepG2凋亡和增殖的影响[J]. 临床荟萃, 2014, 29(1): 45-48.
[6]	邵建政. 抗甲状腺药物和放射性碘对治疗Graves病疗效的观察与评价[J]. 临床荟萃, 2013, 28(12): 1411-1412.
[7]	黄天韬. Craves病患者血清白细胞介素18与胰岛素抵抗的关系[J]. 临床荟萃, 2013, 28(10): 1143-1144.
[8]	尹贺欣;张桂玲;刘涛;刘莉. Graves病合并肝损害与高敏C反应蛋白相关性研究[J]. 临床荟萃, 2012, 27(10): 879-880.
[9]	李莉华. 左旋甲状腺素联合泼尼松治疗活动期Graves眼病的疗效观察[J]. 临床荟萃, 2011, 26(11): 981-983.
[10]	吕碧锋;洪闽女. 低钾性瘫痪63例临床分析[J]. 临床荟萃, 2010, 25(24): 2158-2159.
[11]	唐汝新;胡玲玲. 格雷夫斯病患者的体液免疫功能分析[J]. 临床荟萃, 2010, 25(20): 1783-1785.
[12]	王晓燕;郭志英. 急诊低钾性周期性麻痹94例临床分析[J]. 临床荟萃, 2010, 25(16): 1416-1417.
[13]	张桂玲;耿娜;南海燕;谭博;刘莉;李继. 格雷夫斯病合并肝损害与甲状腺自身抗体及激素水平的关系[J]. 临床荟萃, 2009, 24(24): 2162-2164.
[14]	于红艳;刘红;魏东敏;王玉芬. 甲状腺功能亢进及减退患者血清瘦素水平的变化[J]. 临床荟萃, 2009, 24(23): 2069-2070.
[15]	曾建业;何凤屏;梁驰;叶学和;潘革;阳世雄;李山. 碘摄入量及易感HLA基因与广西沿海地区Graves病的相关性研究[J]. 临床荟萃, 2009, 24(22): 1937-1940.

甲状腺毒症周期性瘫痪与rs312691多态性关联的meta分析

Association between rs312691 polymorphism and susceptibility to thyrotoxic periodic paralysis: a metaanalysis

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价